Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that it has appointed Brendan O’Brien to its strategic advisory board.
Help employers find you! Check out all the jobs and post your resume.
